These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38519745)

  • 1. Artificial intelligence algorithm accurately assesses oestrogen receptor immunohistochemistry in metastatic breast cancer cytology specimens: A pilot study.
    Li BC; Hammond S; Parwani AV; Shen R
    Cytopathology; 2024 Jul; 35(4):464-472. PubMed ID: 38519745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating and validating automated digital imaging analysis of estrogen receptor immunohistochemistry in a fully digital workflow for clinical use.
    Shafi S; Kellough DA; Lujan G; Satturwar S; Parwani AV; Li Z
    J Pathol Inform; 2022; 13():100122. PubMed ID: 36268080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 cases.
    Jung M; Song SG; Cho SI; Shin S; Lee T; Jung W; Lee H; Park J; Song S; Park G; Song H; Park S; Lee J; Kang M; Park J; Pereira S; Yoo D; Chung K; Ali SM; Kim SW
    Breast Cancer Res; 2024 Feb; 26(1):31. PubMed ID: 38395930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Intelligence-Aided Diagnosis of Breast Cancer Lymph Node Metastasis on Histologic Slides in a Digital Workflow.
    Challa B; Tahir M; Hu Y; Kellough D; Lujan G; Sun S; Parwani AV; Li Z
    Mod Pathol; 2023 Aug; 36(8):100216. PubMed ID: 37178923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an artificial intelligence algorithm for assisting the Paris System in reporting urinary cytology: A pilot study.
    Ou YC; Tsao TY; Chang MC; Lin YS; Yang WL; Hang JF; Li CB; Lee CM; Yeh CH; Liu TJ
    Cancer Cytopathol; 2022 Nov; 130(11):872-880. PubMed ID: 35727052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Fully Automated Artificial Intelligence System to Assist Pathologists' Diagnosis to Predict Histologically High-grade Urothelial Carcinoma from Digitized Urine Cytology Slides Using Deep Learning.
    Tsuji K; Kaneko M; Harada Y; Fujihara A; Ueno K; Nakanishi M; Konishi E; Takamatsu T; Horiguchi G; Teramukai S; Ito-Ihara T; Ukimura O
    Eur Urol Oncol; 2024 Apr; 7(2):258-265. PubMed ID: 38065702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated imaging analysis of Ki-67 immunohistochemistry on whole slide images of cell blocks from pancreatic neuroendocrine neoplasms.
    Shaker N; Shen R; Limbach AL; Satturwar S; Kobalka P; Ahmadian S; Sun S; Chen W; Lujan G; Esnakula A; Parwani A; Li Z
    J Am Soc Cytopathol; 2024; 13(3):205-212. PubMed ID: 38433072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fully Automated Artificial Intelligence Solution for Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Scoring in Breast Cancer: A Multireader Study.
    Krishnamurthy S; Schnitt SJ; Vincent-Salomon A; Canas-Marques R; Colon E; Kantekure K; Maklakovski M; Finck W; Thomassin J; Globerson Y; Bien L; Mallel G; Grinwald M; Linhart C; Sandbank J; Vecsler M
    JCO Precis Oncol; 2024 Oct; 8():e2400353. PubMed ID: 39393036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer.
    Shamai G; Binenbaum Y; Slossberg R; Duek I; Gil Z; Kimmel R
    JAMA Netw Open; 2019 Jul; 2(7):e197700. PubMed ID: 31348505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision HER2: a comprehensive AI system for accurate and consistent evaluation of HER2 expression in invasive breast Cancer.
    Xiong Z; Liu K; Liu S; Feng J; Wang J; Feng Z; Lai B; Zhang Q; Jiang Q; Zhang W
    BMC Cancer; 2024 Sep; 24(1):1204. PubMed ID: 39350085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial Intelligence Helps Pathologists Increase Diagnostic Accuracy and Efficiency in the Detection of Breast Cancer Lymph Node Metastases.
    Retamero JA; Gulturk E; Bozkurt A; Liu S; Gorgan M; Moral L; Horton M; Parke A; Malfroid K; Sue J; Rothrock B; Oakley G; DeMuth G; Millar E; Fuchs TJ; Klimstra DS
    Am J Surg Pathol; 2024 Jul; 48(7):846-854. PubMed ID: 38809272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial intelligence for assisted HER2 immunohistochemistry evaluation of breast cancer: A systematic review and meta-analysis.
    Wu S; Li X; Miao J; Xian D; Yue M; Liu H; Fan S; Wei W; Liu Y
    Pathol Res Pract; 2024 Aug; 260():155472. PubMed ID: 39053133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.
    Rexhepaj E; Brennan DJ; Holloway P; Kay EW; McCann AH; Landberg G; Duffy MJ; Jirstrom K; Gallagher WM
    Breast Cancer Res; 2008; 10(5):R89. PubMed ID: 18947395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninferiority of Artificial Intelligence-Assisted Analysis of Ki-67 and Estrogen/Progesterone Receptor in Breast Cancer Routine Diagnostics.
    Abele N; Tiemann K; Krech T; Wellmann A; Schaaf C; Länger F; Peters A; Donner A; Keil F; Daifalla K; Mackens M; Mamilos A; Minin E; Krümmelbein M; Krause L; Stark M; Zapf A; Päpper M; Hartmann A; Lang T
    Mod Pathol; 2023 Mar; 36(3):100033. PubMed ID: 36931740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the oestrogen and progesterone receptor status in primary breast carcinomas as evaluated by immunohistochemistry and immunocytochemistry: a consecutive series of 267 patients.
    Domanski AM; Monsef N; Domanski HA; Grabau D; Fernö M
    Cytopathology; 2013 Feb; 24(1):21-5. PubMed ID: 22783929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Validation Study of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Digital Imaging Analysis and its Correlation with Human Epidermal Growth Factor Receptor 2 Fluorescence
    Hartage R; Li AC; Hammond S; Parwani AV
    J Pathol Inform; 2020; 11():2. PubMed ID: 32154039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence-based automated determination in breast and colon cancer and distinction between atypical and typical mitosis using a cloud-based platform.
    Bakoglu N; Cesmecioglu E; Sakamoto H; Yoshida M; Ohnishi T; Lee SY; Smith L; Yagi Y
    Pathol Oncol Res; 2024; 30():1611815. PubMed ID: 39539960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Artificial Intelligence in Accurate Interpretation of HER2 Immunohistochemical Scores 0 and 1+ in Breast Cancer.
    Wu S; Yue M; Zhang J; Li X; Li Z; Zhang H; Wang X; Han X; Cai L; Shang J; Jia Z; Wang X; Li J; Liu Y
    Mod Pathol; 2023 Mar; 36(3):100054. PubMed ID: 36788100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implementation of artificial-intelligence-assisted detection of breast cancer metastases in sentinel lymph nodes: the CONFIDENT-B single-center, non-randomized clinical trial.
    van Dooijeweert C; Flach RN; Ter Hoeve ND; Vreuls CPH; Goldschmeding R; Freund JE; Pham P; Nguyen TQ; van der Wall E; Frederix GWJ; Stathonikos N; van Diest PJ
    Nat Cancer; 2024 Aug; 5(8):1195-1205. PubMed ID: 38937624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can AI-assisted microscope facilitate breast HER2 interpretation? A multi-institutional ring study.
    Yue M; Zhang J; Wang X; Yan K; Cai L; Tian K; Niu S; Han X; Yu Y; Huang J; Han D; Yao J; Liu Y
    Virchows Arch; 2021 Sep; 479(3):443-449. PubMed ID: 34279719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.